Biofilms protect Mycoplasma pulmonis cells from lytic effects of complement and gramicidin

Infection and Immunity

Volumn 75, Issue 8, 2007, Pages 3696-3699

  Simmons, Warren L ^a   Dybvig, Kevin ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; COMPLEMENT; GRAMICIDIN; PROTEIN VSA; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL CELL; BACTERICIDAL ACTIVITY; BIOFILM; CYTOLYSIS; HOST; IMMUNITY; MYCOPLASMA PULMONIS; NONHUMAN; PRIORITY JOURNAL; TANDEM REPEAT;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BIOFILMS; COLONY COUNT, MICROBIAL; COMPLEMENT SYSTEM PROTEINS; DRUG RESISTANCE, BACTERIAL; GRAMICIDIN; MICROBIAL VIABILITY; MICROSCOPY, FLUORESCENCE; MYCOPLASMA PULMONIS;

EID: 34547629065     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00440-07     Document Type: Article

References (16)

1. Anwar, H., J. L. Strap, and J. W. Costerton. 1992. Susceptibility of biofilm cells of Pseudomonas aeruginosa to bactericidal actions of whole blood and serum. FEMS Microbiol. Lett. 71:235-241.
2. Campos, M. A., M. A. Vargas, V. Regueiro, C. M. Llompart, S. Alberti, and J. A. Bengoechea. 2004. Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect. Immun. 72:7107-7114.
3. Costerton, J. W., P. S. Stewart, and E. P. Greenberg. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322.
4. Denison, A. M., B. Clapper, and K. Dybvig. 2005. Avoidance of the host immune system through phase variation in Mycoplasma pulmonis. Infect. Immun. 73:2033-2039.
5. Fassi-Fehri, L., H. Wroblewski, and A. Blanchard. 2007. Activities of antimicrobial peptides and synergy with enrofloxacin against Mycoplasma pulmonis. Antimicrob. Agents Chemother. 51:468-474.
6. Fehri, L. F., P. Sirand-Pugnet, G. Gourgues, G. Jan, H. Wroblewski, and A. Blanchard. 2005. Resistance to antimicrobial peptides and stress response in Mycoplasma pulmonis. Antimicrob. Agents Chemother. 49:4154-4165.
7. Greiner, L. L., J. L. Edwards, J. Shao, C. Rabinak, D. Entz, and M. A. Apicella. 2005. Biofilm formation by Neisseria gonorrhoeae. Infect. Immun. 73:1964-1970.
8. Jensen, E. T., A. Kharazmi, P. Garred, G. Kronborg, A. Fomsgaard, T. E. Mollnes, and N. Hoiby. 1993. Complement activation by Pseudomonas aeruginosa biofilms. Microb. Pathog. 15:377-388.
9. McAuliffe, L., R. J. Ellis, K. Miles, R. D. Ayling, and R. A. J. Nicholas. 2006. Biofilm formation by mycoplasma species and its role in environmental persistence and survival. Microbiology 152:913-922.
10. Shen, X., J. Gumulak, H. Yu, C. T. French, N. Zou, and K. Dybvig. 2000. Gene rearrangements in the vsa locus of Mycoplasma pulmonis. J. Bacteriol. 182:2900-2908.
11. Simmons, W. L., J. R. Bolland, J. M. Daubenspeck, and K. Dybvig. 2007. A stochastic mechanism for biofilm formation by Mycoplasma pulmonis. J. Bacteriol. 189:1905-1913.
12. Simmons, W. L., A. M. Denison, and K. Dybvig. 2004. Resistance of Mycoplasma pulmonis to complement lysis is dependent on the number of Vsa tandem repeats: shield hypothesis. Infect. Immun. 72:6846-6851.
13. Simmons, W. L., and K. Dybvig. 2003. The Vsa proteins modulate susceptibility of Mycoplasma pulmonis to complement, hemadsorption, and adherence to polystyrene. Infect. Immun. 71:5733-5738.
14. Stadtländer, C. T., H. L. Watson, J. W. Simecka, and G. H. Cassell. 1991. Cytopathic effects of Mycoplasma pulmonis in vivo and in vitro. Infect. Immun. 59:4201-4211.
15. Vuong, C., J. M. Voyich, E. R. Fischer, K. R. Braughton, A. R. Whitney, F. R. DeLeo, and M. Otto. 2004. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell. Microbiol. 6:269-275.
16. Webb, J. S., L. S. Thompson, S. S. James, T. Charlton, T. Tolker-Nielsen, B. Koch, M. Givskov, and S. Kjelleberg. 2003. Cell death in Pseudomonas aeruginosa biofilm development. J. Bacteriol. 185:4585-4592.